Loading...
Loading...
ESTA| Name | Value |
|---|---|
| Revenues | 38.5M |
| Cost of Revenue | 12.5M |
| Gross Profit | 26.1M |
| Operating Expense | 47.1M |
| Operating I/L | -21.0M |
| Other Income/Expense | -7.6M |
| Interest Income | 0.3M |
| Pretax | -28.6M |
| Income Tax Expense | -0.7M |
| Net Income/Loss | -29.3M |
Establishment Labs Holdings Inc. is a medical technology company specializing in the manufacturing and marketing of medical devices for aesthetic and reconstructive plastic surgery. The company's primary revenue-generating products are silicone gel-filled breast implants, including the Motiva Implants brand, Motiva Ergonomix, and Motiva Ergonomix2 gravity-sensitive round soft silicone-gel-filled breast implants, as well as the Motiva Flora Tissue Expander. Additionally, the company distributes the Puregraft line of products for autologous adipose tissue harvesting and redistribution. Establishment Labs Holdings Inc. generates revenue through the sale of these products via exclusive distributors and a direct sales force across various regions, including Europe, Latin America, the Asia-Pacific, and internationally.
